BRISTOL MYERS SQUIBB CO
For the period ended Dec 31, 2023. Filed Feb 13, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 13, 2024
BMY$62.140.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
Dollars in millions, except share and per share data
| December 31, | ||
|---|---|---|
| ASSETS | 2023 | 2022 |
| Current Assets: | ||
| Cash and cash equivalents | $11,464 | $9,123 |
| Marketable debt securities | 816 | 130 |
| Receivables | 10,921 | 9,886 |
| Inventories | 2,662 | 2,339 |
| Other current assets | 5,907 | 5,795 |
| Total Current assets | 31,770 | 27,273 |
| Property, plant and equipment | 6,646 | 6,255 |
| Goodwill | 21,169 | 21,149 |
| Other intangible assets | 27,072 | 35,859 |
| Deferred income taxes | 2,768 | 1,344 |
| Marketable debt securities | 364 | — |
| Other non-current assets | 5,370 | 4,940 |
| Total Assets | $95,159 | $96,820 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term debt obligations | $3,119 | $4,264 |
| Accounts payable | 3,259 | 3,040 |
| Other current liabilities | 15,884 | 14,586 |
| Total Current liabilities | 22,262 | 21,890 |
| Deferred income taxes | 338 | 2,166 |
| Long-term debt | 36,653 | 35,056 |
| Other non-current liabilities | 6,421 | 6,590 |
| Total Liabilities | 65,674 | 65,702 |
| Commitments and contingencies | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders’ Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 2,953 in 2023 and 2,991 in 2022, liquidation value of $50 per share | — | — |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.9 billion issued in 2023 and 2022 | 292 | 292 |
| Capital in excess of par value of stock | 45,684 | 45,165 |
| Accumulated other comprehensive loss | (1,546) | (1,281) |
| Retained earnings | 28,766 | 25,503 |
| Less cost of treasury stock — 902 million common shares in 2023 and 825 million common shares in 2022 | (43,766) | (38,618) |
| Total BMS Shareholders’ Equity | 29,430 | 31,061 |
| Noncontrolling interest | 55 | 57 |
| Total Equity | 29,485 | 31,118 |
| Total Liabilities and Equity | $95,159 | $96,820 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.